Skip to main content
SpringerLink
Log in

Epstein-barr virus-associated composite lymphoma composed of peripheral t-cell lymphoma and an anaplastic variant of a diffuse large b-cell type of non-hodgkin’s lymphoma and strongly expressing P53 protein

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

We report a case of composite lymphoma consisting of peripheral T-cell lymphoma and an anaplastic variant of diffuse large B-cell lymphoma (DLBCL) and associated with Epstein-Barr virus (EBV) infection and strong p53 expression. A 65-year-old Japanese woman developed fever and generalized lymphadenopathy.A biopsy of the cervical node revealed the morphology of malignant lymphoma with 2 kinds of lymphoma coexisting in 1 lymph node. One lymphoma type consisted of immunoblastic large cells with the T-cell marker phenotype CD3+, CD45RO/UCHL-1+, CD20/L26-, CD79-, CD10-, CD30-, and CD15-; the other type consisted of large cells with abundant cytoplasm and pleomorphic nuclei with the marker phenotype CD79+, CD20/ L26+, CD45RO/UCHL-1-, CD3-, CD10-, CD30+, NPM/ALK-, and CD15-. Therefore, the diagnosis was composite lymphoma of peripheral T-cell lymphoma and an anaplastic variant of DLBCL, stage IVB, because the patient had bone marrow involvement with peripheral T-cell lymphoma. The biopsy led to findings of latent type II EBV-associated lymphoma in both the peripheral T-cell lymphoma and the anaplastic variant of DLBCL as the result of positive signals for EBV small RNAs by in situ hybridization, positive immunostaining results for EBV latent membrane protein 1 antibody, and negative immunostaining results for EBV nuclear antigen 2. Immunostaining of the mass with p53 antibody also yielded positive results for both types of lymphoma cells. This case suggests that the immunocompromised state of this patient with EBV-related peripheral T-cell lymphoma allowed the emergence of an EBV-related anaplastic variant of DLBCL and suggests a close relationship between p53 expression and latent EBV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kim H, Hendrickson MR, Dorfman RF. Composite lymphoma. Cancer. 1977;40:959–976.

    Article  PubMed  CAS  Google Scholar 

  2. Kim H. Composite lymphoma and related disorders. Am J Clin Pathol. 1993;99:445–451.

    Article  PubMed  CAS  Google Scholar 

  3. Gonzalez CL, Meroides LJ, Jaffe ES. Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Am J Clin Pathol. 1991;96:81–89.

    Article  PubMed  CAS  Google Scholar 

  4. Tobinai K, Ohtsu T, Hayashi M, et al. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. Leuk Res. 1991;15:837–846.

    Article  PubMed  CAS  Google Scholar 

  5. Strickler JG, Amsden TW, Kurtin PJ. Small B-cell lymphoid neoplasms with coexisting T-cell lymphomas. Am J Clin Pathol. 1992; 98:424–429.

    Article  PubMed  CAS  Google Scholar 

  6. Liu YC, Tomashefski JF Jr, Cleveland RP, et al. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, and molecular genetic documentation of concurrent lymph node involvement. Mod Pathol. 1994;7:641–646.

    PubMed  CAS  Google Scholar 

  7. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002;117:368–379.

    Article  PubMed  Google Scholar 

  8. Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe ES. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification:Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:230–235.

    Google Scholar 

  9. Borisch B, Finke J, Hennig I, et al. Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol. 1992;168: 229–236.

    Article  PubMed  CAS  Google Scholar 

  10. Hamilton-Dutroit SJ, Raphael M, Audouin J, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood. 1993;82:619–624.

    Google Scholar 

  11. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981;41:4253–4261.

    PubMed  CAS  Google Scholar 

  12. Penn I. Malignant lymphomas in organ transplant recipients. Transplant Proc. 1981;13:736–738.

    PubMed  CAS  Google Scholar 

  13. Kamel OW, van de Riin M, Weiss LM, et al. Brief report: reversible lymphoma associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328:1317–1321.

    Article  PubMed  CAS  Google Scholar 

  14. Dawson TM, Starkebaum G, Wood BL, Wilkins RF, Gown AM. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren’s syndrome: case series. J Rheumatol. 2001;28:47–53.

    PubMed  CAS  Google Scholar 

  15. Hirose Y, Masaki Y, Okada J, et al. Epstein-Barr virus associated B-cell type non-Hodgkin’s lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate. Int J Hematol. 2002;75:412–415.

    Article  Google Scholar 

  16. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin’s disease and Ki-1- positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood. 1989;74:810–816.

    CAS  Google Scholar 

  17. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood. 1991;78:2666–2673.

    CAS  Google Scholar 

  18. Shimakage M, Nakamine H, Tamura S, Takenaka T, Yutsudo M, Hakura H. Detection of Epstein-Barr virus transcript in anaplastic large-cell lymphomas by mRNA in situ hybridization. Hum Pathol. 1997;28:1415–1419.

    Article  CAS  Google Scholar 

  19. Hirose Y, Masaki Y, Shimoyama K, et al. Epstein-Barr virus-associated anaplastic large cell variant of diffuse large B-cell-type non-Hodgkin’s lymphoma with concurrent p53 protein expression. Int J Hematol. 2003;77:499–502.

    Article  Google Scholar 

  20. Szekely W, Selivanova G, Magnusson KP, et al. EBNA-5, an Epstein- Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A. 1993;90:5455–5459.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Chen W, Cooper NR. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-βB activity. J Virol. 1996;70:4849–4853.

    PubMed  PubMed Central  CAS  Google Scholar 

  22. Shibata D, Weiss LM, Nathwani BN, et al. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin’s lymphoma. Blood. 1991;77: 1527–1533.

    PubMed  CAS  Google Scholar 

  23. Hirose Y, Masaki Y, Shimizu S, et al. Association of Epstein-Barr virus with human immunodeficiency virus-negative T cell lymphomas in Japan, in situ hybridization, polymerase chain reaction and immunohistochemical studies. Leukemia. 1996;10:1673–1675.

    PubMed  CAS  Google Scholar 

  24. Khan G, Norton AJ, Slavin G. Epstein-Barr virus in angioimmunoblastic T-cell lymphomas. Histopathology. 1993;22:145–149.

    Article  PubMed  CAS  Google Scholar 

  25. Menke DM, Griesser H, Moder KG, et al. Lymphomas in patients with connective tissue disease: comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol. 2000; 113:212–218.

    Article  PubMed  CAS  Google Scholar 

  26. Bartek J, Bartkova J, Vojtesek B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991;6:1699–1703.

    PubMed  CAS  Google Scholar 

  27. Edwards RH, Raab-Traub N. Alterations of p53 gene in Epstein- Barr virus-associated immunodeficiency-related lymphomas. J Virol. 1994;68:1309–1315.

    PubMed  PubMed Central  CAS  Google Scholar 

  28. Cesarman E, Inghirami G, Chadburn A, et al. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol. 1993;143:845–856.

    PubMed  PubMed Central  CAS  Google Scholar 

  29. Szekely L, Selivanova G, Magnusson KP, et al. EBNA-5, an Epstein- Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A. 1993;90:5459–5459.

    Article  Google Scholar 

  30. Chen W, Cooper NR. Epstein-Barr virus nuclear antigen-2 and latent membrane protein independently transactivate p53 through induction of NF-βB activity. J Virol. 1996;70:4849–4853.

    PubMed  PubMed Central  CAS  Google Scholar 

  31. Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16–26.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan

    Yuko Hirose, Toshihiro Fukushima, Yasufumi Masaki, Kumiko Shimoyama, Hiromi Karasawa, Noriyoshi Ogawa & Yuji Wano

Authors
  1. Yuko Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshihiro Fukushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasufumi Masaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kumiko Shimoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiromi Karasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Noriyoshi Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuji Wano
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Hirose, Y., Fukushima, T., Masaki, Y. et al. Epstein-barr virus-associated composite lymphoma composed of peripheral t-cell lymphoma and an anaplastic variant of a diffuse large b-cell type of non-hodgkin’s lymphoma and strongly expressing P53 protein. Int J Hematol 79, 260–265 (2004). https://doi.org/10.1532/IJH97.03156

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.03156

Key words

Search

Navigation